|
22
|
Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)
PAR-25-103 · National Institutes of Health · applied research
|
biomedical clinical
public health
mental behavioral health
|
— |
2024-11-05 |
2027-10-25 |
354 |
|
20
|
Effectiveness Trials to Test Mental Health System Interventions (R61/R33 Clinical Trial Required)
PAR-25-285 · National Institutes of Health · applied research
|
mental behavioral health
public health
social services
|
— |
2024-11-26 |
2027-10-15 |
344 |
|
18
|
Screening, Brief Intervention and Referral to Treatment or Prevention (SBIRT/P) for alcohol, tobacco, and other drugs (ATOD) use and misuse in adult populations that experience health disparities (R01, Clinical Trial Required)
PAR-26-001 · National Institutes of Health · applied research
|
public health
biomedical clinical
mental behavioral health
|
— |
2024-11-21 |
2027-05-07 |
183 |
|
18
|
BRAIN Initiative: Brain Behavior Quantification and Synchronization- Next Generation Sensor Technology Development (U01 Clinical Trial Optional)
RFA-MH-26-140 · National Institutes of Health · applied research
|
biomedical clinical
mental behavioral health
ai data science
|
— |
2024-10-23 |
2027-06-15 |
222 |
|
18
|
D-START: Data Science Track Award for Research Transition (D/START) (R03-Clinical Trial Optional)
PAS-25-236 · National Institutes of Health · applied research
|
public health
biomedical clinical
ai data science
|
$100,000 |
2024-12-16 |
2027-09-07 |
306 |
|
18
|
Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)
PAR-24-330 · National Institutes of Health · applied research
|
public health
biomedical clinical
mental behavioral health
|
— |
2024-12-06 |
2027-09-07 |
306 |
|
18
|
Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)
PAR-25-104 · National Institutes of Health · applied research
|
biomedical clinical
public health
mental behavioral health
|
— |
2024-11-05 |
2027-10-25 |
354 |
|
18
|
Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)
PAR-25-100 · National Institutes of Health · applied research
|
public health
biomedical clinical
mental behavioral health
|
— |
2024-12-06 |
2027-10-27 |
356 |
|
15
|
Pilot Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 Clinical Trial Required)
PAR-25-178 · National Institutes of Health · applied research
|
mental behavioral health
public health
biomedical clinical
|
— |
2024-11-26 |
2027-10-15 |
344 |
|
15
|
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01 Clinical Trial Optional)
PAR-25-352 · National Institutes of Health · applied research
|
biomedical clinical
mental behavioral health
ai data science
|
— |
2025-01-15 |
2027-10-25 |
354 |
|
14
|
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)
PAR-25-182 · National Institutes of Health · applied research
|
mental behavioral health
public health
biomedical clinical
|
— |
2024-11-26 |
2027-10-15 |
344 |
|
12
|
Full-Scale Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 - Clinical Trial Required)
PAR-25-177 · National Institutes of Health · applied research
|
mental behavioral health
public health
biomedical clinical
|
— |
2024-11-26 |
2027-10-15 |
344 |
|
12
|
Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)
PAR-25-181 · National Institutes of Health · applied research
|
mental behavioral health
biomedical clinical
education workforce
|
— |
2024-11-26 |
2027-10-15 |
344 |
|
7
|
Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)
PAR-25-184 · National Institutes of Health · applied research
|
mental behavioral health
biomedical clinical
ai data science
|
— |
2024-11-26 |
2027-10-15 |
344 |
|
6
|
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)
PAR-25-353 · National Institutes of Health · applied research
|
biomedical clinical
mental behavioral health
materials manufacturing
|
— |
2025-01-15 |
2027-10-25 |
354 |
|
5
|
Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
PAR-24-293 · National Institutes of Health · applied research
|
biomedical clinical
mental behavioral health
computing communications
|
— |
2024-10-01 |
2027-08-18 |
286 |